We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2 for:    NCT01183455
Previous Study | Return to List | Next Study

A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II (RETAIN)

This study has been withdrawn prior to enrollment.
(Sponsor decision-lack of mechanistic signal and competing industry studies)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01183455
First Posted: August 17, 2010
Last Update Posted: December 31, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Immune Tolerance Network (ITN)
Juvenile Diabetes Research Foundation
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)